Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)

Historic Current Taxes for Protagonist Therapeutics (PTGX) over the last 3 years, with Q1 2025 value amounting to $1.9 million.

  • Protagonist Therapeutics' Current Taxes fell 4320.51% to $1.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.9 million, marking a year-over-year decrease of 4320.51%. This contributed to the annual value of $2.7 million for FY2024, which is N/A changed from last year.
  • Protagonist Therapeutics' Current Taxes amounted to $1.9 million in Q1 2025, which was down 4320.51% from $2.7 million recorded in Q4 2024.
  • Protagonist Therapeutics' Current Taxes' 5-year high stood at $3.3 million during Q1 2024, with a 5-year trough of $1.0 million in Q3 2024.